The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
EMPAVELI®(pegcetacoplan) is the first approved treatment for C3G or primary IC-MPGN for patients 12 years and older in CanadaApproval supported ...
Yale researchers have previously shown that people who undergo moderate calorie restriction—a 14% reduction in calorie intake ...
Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...
"AstraZeneca to seek accelerated approval of Ultomirisin in IgAN on Phase III data" was originally created and published by ...
Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the ...
This £125 floral mirror blends art and function, brightens rooms, and offers an easy stylish upgrade for modern interiors.
Once global warming peaks, it will take centuries to cool things back down. But we can bend the curve by cutting fossil fuel ...
CLEVELAND, Ohio — With the 2026 NFL Draft approaching, the New York Giants appear headed toward one of the more intriguing ...
Increasingly, businesses are turning to independent cybersecurity subject matter experts (SMEs), like Duffy Compliance ...
Researchers have identified a new method for analyzing chest CT scans that may help physicians better understand the different forms of sarcoidosis, a complex inflammatory lung disease that affects ...
As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results